| Schedule of condensed consolidated balance Sheet |
| Condensed Consolidated Balance Sheet as of September 30, 2021 | |
As
Previously Reported | | |
Adjustment | | |
As Restated | |
| Additional paid-in capital | |
$ | 671,906 | | |
$ | 4,362 | | |
$ | 676,268 | |
| Accumulated deficit | |
$ | (429,855 | ) | |
$ | (4,362 | ) | |
$ | (434,217 | ) |
|
| Schedule of condensed consolidated statement of operations |
| Condensed Consolidated Statement of Operations for the Three Months Ended September 30, 2021 | |
As
Previously
Reported | | |
Adjustment | | |
As Restated | |
| | |
(amounts in thousands except share and per share amounts) | |
| Change in fair value of warrant liability | |
$ | (6,551 | ) | |
$ | 12,046 | | |
$ | 5,495 | |
| Change in fair value of subordinated convertible notes | |
$ | - | | |
$ | (7,684 | ) | |
$ | (7,684 | ) |
| Total operating expenses | |
$ | 64,504 | | |
$ | 4,362 | | |
$ | 68,866 | |
| Net loss before income taxes | |
$ | (20,284 | ) | |
$ | (4,362 | ) | |
$ | (24,646 | ) |
| Net loss | |
$ | (20,283 | ) | |
$ | (4,362 | ) | |
$ | (24,645 | ) |
| Net income attributable to common shareholders | |
$ | 28,663 | | |
$ | (4,362 | ) | |
$ | 23,401 | |
| Net income per share, basic | |
$ | 0.46 | | |
$ | (0.07 | ) | |
$ | 0.39 | |
| Net income per share, diluted | |
$ | 0.46 | | |
$ | (0.33 | ) | |
$ | 0.13 | |
| Weighted average shares used in computing net loss per share, diluted | |
| 62,314,396 | | |
| 156,799,692 | | |
| 219,114,088 | |
| Condensed Consolidated Statement of Operations for the Nine Months Ended September 30, 2021 |
|
As
Previously
Reported |
|
Adjustment |
|
As Restated |
| |
|
(amounts in thousands except per share amounts) |
| Change in fair value of warrant liability |
|
$ |
42,239 |
|
|
$ |
12,046 |
|
|
$ |
54,285 |
|
| Change in fair value of subordinated convertible notes |
|
$ |
49,561 |
|
|
$ |
(7,684 |
) |
|
$ |
41,877 |
|
| Total operating expenses |
|
$ |
248,386 |
|
|
$ |
4,362 |
|
|
$ |
252,748 |
|
| Net loss before income taxes |
|
$ |
(132,837 |
) |
|
$ |
(4,362 |
) |
|
$ |
(137,199 |
) |
| Net loss |
|
$ |
(132,878 |
) |
|
$ |
(4,362 |
) |
|
$ |
(137,240 |
) |
| Net income attributable to common shareholders |
|
$ |
(99,514 |
) |
|
$ |
(4,362 |
) |
|
$ |
(103,876 |
) |
| Net income per share, basic and diluted |
|
$ |
(1.87 |
) |
|
$ |
(0.09 |
) |
|
$ |
(1.96 |
) |
|
| Schedule of condensed consolidated statement of cash flows |
| Condensed Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2021 | |
As
Previously
Reported | | |
Adjustment | | |
As Restated | |
| Net loss | |
$ | (132,878 | ) | |
$ | (4,362 | ) | |
$ | (137,240 | ) |
| Change in fair value of warrants | |
$ | 42,239 | | |
$ | 12,046 | | |
$ | 54,285 | |
| Change in fair value of subordinated convertible notes | |
$ | 49,561 | | |
$ | (7,684 | ) | |
$ | 41,877 | |
| Issuance of common stock related to convertible debt | |
$ | 100,311 | | |
$ | (7,684 | ) | |
$ | 92,627 | |
| Issuance of common stock related to warrants exercised | |
$ | 73,456 | | |
$ | 12,046 | | |
$ | 85,502 | |
|